Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Latent-transforming growth factor β-binding protein 1/Transforming growth factor β1 complex drives antitumoral effects upon ERK5 targeting in melanoma.
Am J Pathol. 2024 May 3:S0002-9440(24)00167-6. doi: 10.1016/j.ajpath.2024.03.015. Online ahead of print.
Am J Pathol. 2024.
PMID: 38705382
Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.
Tubita A, Lombardi Z, Tusa I, Lazzeretti A, Sgrignani G, Papini D, Menconi A, Gagliardi S, Lulli M, Dello Sbarba P, Esparís-Ogando A, Pandiella A, Stecca B, Rovida E.
Tubita A, et al. Among authors: lombardi z.
Cancer Res. 2022 Feb 1;82(3):447-457. doi: 10.1158/0008-5472.CAN-21-0993. Epub 2021 Nov 19.
Cancer Res. 2022.
PMID: 34799355
Free PMC article.
Item in Clipboard
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features.
Tusa I, Cheloni G, Poteti M, Silvano A, Tubita A, Lombardi Z, Gozzini A, Caporale R, Scappini B, Dello Sbarba P, Rovida E.
Tusa I, et al. Among authors: lombardi z.
Target Oncol. 2020 Oct;15(5):659-671. doi: 10.1007/s11523-020-00741-x.
Target Oncol. 2020.
PMID: 32780298
Free PMC article.
Item in Clipboard
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.
Tubita A, Lombardi Z, Tusa I, Dello Sbarba P, Rovida E.
Tubita A, et al. Among authors: lombardi z.
Int J Mol Sci. 2020 Jan 31;21(3):938. doi: 10.3390/ijms21030938.
Int J Mol Sci. 2020.
PMID: 32023850
Free PMC article.
Review.
Item in Clipboard
Cite
Cite